Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, September 2000, p. 745-750, Vol. 7, No. 5
Australian Environmental Flow Cytometry
Group, School of Biological Sciences, Macquarie University, Sydney,
New South Wales 2109,2 Proteosome
Systems Limited, North Ryde, New South Wales
2113,3 and BioTechnology Frontiers,
North Ryde BC, New South Wales 1670,1 Australia
Received 29 November 1999/Returned for modification 10 March
2000/Accepted 17 May 2000
The detection of Cryptosporidium oocysts in drinking
water is critically dependent on the quality of immunofluorescent
reagents. Experiments were performed to develop a method for producing
highly specific antibodies to Cryptosporidium oocysts that
can be used for water testing. BALB/c mice were immunized with six
different antigen preparations and monitored for immunoglobulin G (IgG) and IgM responses to the surface of Cryptosporidium
oocysts. One group of mice received purified oocyst walls, a second
group received a soluble protein preparation extracted from the outside
of the oocyst wall, and the third group received whole inactivated
oocysts. Three additional groups were immunized with sequentially
prepared oocyst extracts to provide for a comparison of the immune
response. Mice injected with the soluble protein extract demonstrated
an IgG response to oocysts surface that was not seen in the
whole-oocyst group. Mice injected with whole oocysts showed an IgM
response only, while mice injected with purified oocyst walls showed
little increase in IgM or IgG levels. Of the additional reported
preparations only one, BME (2-mercaptoethanol treated), produced a weak
IgM response to the oocyst wall. A mouse from the soluble oocyst
extract group yielding a high IgG response was utilized to produce a
highly specific IgG1 monoclonal antibody (Cry104) specific
to the oocyst surface. Comparative flow cytometric analysis indicated
that Cry104 has a higher avidity and specificity to oocysts in water
concentrates than other commercially available antibodies.
Cryptosporidium parvum is
a parasitic protozoan (coccidium) which is among the most common causes
of diarrheal disease in humans (14).
Cryptosporidium oocysts are environmentally robust and can
survive in aquatic environments for months (17). These oocysts are also resistant to standard chlorination disinfection used
for drinking water treatment (9, 17). It is a common waterborne disease in western countries, where it accounts for 1 to 2%
of all cases (21), with as few as 30 ingested
Cryptosporidium oocysts causing (4, 20) a profuse
watery diarrhea. Infection in immunocompromised individuals is severe
and prolonged (3).
The detection of low levels of Cryptosporidium in
environmental waters is extremely difficult. Most routinely used
detection methods rely on antibodies to separate oocysts from debris
using techniques such as flow cytometry (22) or
immunomagnetic separation (1). The fluorescently labeled
oocysts are then enumerated using epifluorescent microscopy or flow
cytometry. However, the separation and detection of oocysts is limited
by the specificity of available monoclonal antibodies (MAbs)
(23).
All currently available Cryptosporidium-specific MAbs are
either of the immunoglobulin M (IgM) or IgG3 subclasses
(25), which have been developed for detection in fecal
material rather than for water analysis. IgM MAbs are known to be
larger and more "sticky" than MAbs of the IgG1 subclass
(18). In water these MAbs bind nonspecifically to algal and
mineral particles, resulting in substantial background fluorescence and
false-positive results (24). MAbs of the IgG1 subclass are
usually higher affinity and less sticky, thus greatly reducing
nonspecific binding and cross-reactivity with other organisms
(18). Another advantage of MAbs of the IgG1 subclass is the
ease of purification by methods such as protein A precipitation
(5).
In order to obtain an IgG1 MAb, it is essential to obtain a strong IgG
response to the oocyst surface. In previous studies, immunization with
whole oocysts produced MAbs predominantly to the sporozoite and a few
to the oocyst wall (12). Removal of sporozoites from antigen
preparations may reduce this predominant IgM response. The structure of
the oocyst wall is rich in complex polysaccharides (11), and
this may cause an IgM response. Antigen structure as well as
concentration plays a key role in inducing an immune response
(7). Therefore, removal of sporozoites and reduction of
antigen size and structure were considered key factors to be taken into
account when preparing antigens. In addition, sequentially extracted
oocyst antigens (8) were used to give an idea of the
immunogenicity of different oocyst wall preparations.
In this study the immune response to six oocyst preparations was
evaluated. After the induction of a strong secondary IgG response in
one group (soluble oocyst extract), a subsequent fusion produced a
highly specific IgG1 MAb (Cry104) to the oocyst wall of C. parvum.
Oocyst purification.
Fecal samples positive for C. parvum were obtained from naturally infected calves in Sydney,
Australia. The feces were diluted approximately 1:4 in water and
centrifuged at 5,000 × g for 10 min. The liquid layer
was then discarded, the pellet was resuspended again in water, and the
procedure was repeated. Fatty materials were then removed by
resuspending the pellet in ice-cold 1% NaHCO3 solution,
adding an ice-cold ether layer and centrifuging the mixture at
5,000 × g for 10 min. After centrifugation, the
supernatant containing the fat plug was discarded, the pellet was
resuspended in ice-cold 1% (wt/vol) NaHCO3 solution and
passed through a layer of prewetted nonabsorbent cotton wool, and the
ether extraction step was repeated. After final centrifugation, the
pellet was resuspended in 40 ml of ice-cold 55% (wt/vol) sucrose
solution. Then, 10 ml of ice-cold H2O was slowly added,
assuring two layers were formed, and the sample was centrifuged at
4,000 × g for 20 min. Oocysts were collected from the
surface interface, and the sucrose flotation step was repeated until no
visible contaminating material could be detected. Purified oocysts were
surface sterilized with ice-cold 70% (vol/vol) ethanol for 30 min,
washed once in phosphate-buffered saline (PBS; Oxoid), and stored in
PBS at 4°C.
Purified oocyst wall.
C. parvum oocyst walls were
purified from excysted oocysts using immunomagnetic separation (IMS).
Freshly purified oocysts were excysted (16), and the
percentage of excystation was determined by flow cytometry
(25). Only samples with >99.5% empty oocysts were
processed further.
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
An Immunoglobulin G1 Monoclonal Antibody Highly
Specific to the Wall of Cryptosporidium Oocysts
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
20°C.
Soluble oocyst extract.
Oocysts suspended at
109/ml in 0.5% (wt/vol) sodium dodecyl sulfate (SDS) were
boiled for 1 h. The sample was centrifuged 13,000 × g for 10 min, and the supernatant was precipitated with 5 volumes of acetone at
20°C overnight. After centrifugation (10 min at 13,000 × g), a small white precipitate was resuspended
in sterile PBS. A total of 109 oocysts yielded roughly 600 to 1,200 µg of acetone precipitate, measured using the Bio-Rad
(Hercules, Calif.) DC protein assay with BSA as a standard.
Additional preparations. To give a comparative measure of the immune response, three extracts of oocysts as described by Hornok et al. (8) originally used to orally inoculate chickens were also used for immunization. Briefly, three sequential extraction preparations were prepared. Oocysts were first subjected to freeze-thawing in liquid nitrogen to produce "oocyst cytosol" antigen (OCA). The insoluble material was then treated with Triton X-114 to dissolve membrane-bound proteins (TRE). The remaining insoluble oocyst material was then solubilized in SDS and 2-mercaptoethanol (BME).
Immunization. All mice were initially tail bled to obtain preimmune control serum. Groups of five BALB/c (ARC) female mice 8 to 12 weeks old were immunized by intraperitoneal injection (i.p.) with either an oocyst wall preparation, whole oocysts, soluble protein extract, or the three preparations described by Hornok et al. (8). Each preparation in PBS was emulsified with an equal volume of Freund complete adjuvant. The whole-oocyst control group received 4 × 106 whole heat-inactivated oocysts (80°C, 30 min), and the oocyst wall mice received oocysts walls at 4 × 104/ml. Groups of mice receiving the soluble protein extracts received between 50 and 80 µg of protein.
A second i.p. injection (100 µl) with the same preparations, emulsified in Freund incomplete adjuvant (FIA) were given after 3 weeks. Mice were bled 3 weeks after the second injection to check for immune response. Mice showing strong IgG immune responses were selected for fusions and given two final boosts, one given i.p. 5 days and another given intravenously in PBS 3 days prior to the fusion.Mouse serum IgM and IgG levels.
Blood collected from tail
bleeds was centrifuged at 13,000 × g for 1 min, and
the top layer of serum was stored at
20°C.
Fusion procedure. The fusion procedure employed was that as described by Pererva (15).
Hybridoma screening. Approximately 7 to 14 days after the fusion, the hybridomas visible at ×400 were marked, and 100 µl of tissue culture supernatant was aseptically removed.
To each hybridoma supernatant, 10 µl of 107 oocysts/ml was added and incubated for 15 min at room temperature. A second FITC-labeled anti-mouse antibody (Amrad) was then added (100 µl at 1:50 dilution in 1% [wt/vol] BSA in PBS) and incubated at room temperature for 15 min. Oocysts were analyzed by flow cytometry with high fluorescence indicating supernatant containing anti-Cryptosporidium antibodies. Hybridomas were tested for anti-Cryptosporidium antibodies of IgM or IgG classes, as described for mouse serum antibodies. All positive hybridomas were tested for isotype using a commercial hemagglutination assay (Serotec).SDS-polyacrylamide gel electrophoresis (PAGE) and Western blotting. Oocysts (5 × 107 to 5 × 108/ml) were added to an equal volume of reducing buffer (0.125 M Tris HCl, 3% [wt/vol] SDS, 10% [vol/vol] glycerol, 5% [vol/vol] 2-mercaptoethanol, and 0.02% [wt/vol] bromophenol blue) and boiled for 3 min at 100°C. This reduced sample was then run on a 12% polyacrylamide separating gel with a 5% stacking gel in a Bio-Rad Miniprotean II cell apparatus at 200 V. High- and low-molecular-weight markers (Novex) were run alongside the sample.
SDS-PAGE gels were electroblotted onto nitrocellulose (Microfiltration Systems) employing a wet blotting system (10) at 12 V for 1 h. The nitrocellulose was cut into strips, and each strip was blocked in 2% (wt/vol) milk in PBS. Strips were incubated with mouse serum (diluted 1:1,000) or anti-Cryptosporidium antibodies (i.e., Cry26 at 10 µg/ml) for 1 h at room temperature. After the strips were washed three times in PBS, they were incubated in an alkaline phosphatase-conjugated anti-mouse antibody (Cappel) diluted 1:20 in 2% (wt/vol) milk in PBS and then developed with 0.5 ml of 4-chloro-1-naphthol and 10 µl of H2O2 in 2 ml of PBS.Oocyst staining in water samples. The effectiveness of MAbs for analysis of water samples was evaluated by flow cytometry. Samples (10 liters) of untreated surface water were collected throughout Australia and then concentrated by flocculation (22). A composite water sample was prepared by mixing aliquots from a range of different sites. C. parvum seeded samples consisted of 50 µl of untreated water concentrate and 10 µl of 108 oocyst seeds. Then, 100 µl of hybridoma supernatant (2 µg/ml) was incubated with the seeded samples at room temperature for 20 min, and 100 µl of anti-mouse FITC-conjugated antibody (Silenus; 1:100) was added for a further 20 min. Samples were analyzed by flow cytometry to determine which antibody produced the greatest separation between the immunofluorescent oocyst population and the background fluorescent particles within the water concentrates.
Functional measurement of avidity. Avidity of binding of the FITC-labeled Cryptosporidium-specific antibodies Cry104, Cry26, and Immucell (Immucell, Portland, Oreg.) were estimated as follows. Pure antibodies (20 µg/ml) were serially diluted for 20 double dilutions. Each dilution was then incubated with 107 oocysts for 20 min at room temperature. A negative control of unlabeled oocysts in PBS was also prepared to provide an endpoint for binding. Fluorescence values for each dilution were recorded and plotted to obtain the value for 50% maximal binding to the oocysts. Assumptions were made that the total input antibody is very nearly the same as free antibody; therefore, the dissociation constant (Kd) is proportional to this 50% concentration. The relative affinity (Ka) is then calculated as the reciprocal value.
| |
RESULTS |
|---|
|
|
|---|
Antibody response to C. parvum oocyst surface
epitopes.
Mouse sera were tested by flow cytometry for IgG and IgM
antibodies to the surface of oocysts (Fig.
1). Mice receiving two injections of
purified oocyst walls showed little or no increase in either IgM or IgG
against the oocyst wall. The whole-oocyst control mice responded with
increased IgM levels but produced little or no IgG response. In
contrast, the soluble-protein-extract group produced higher IgG levels
than that of the whole-oocyst control group, but with less IgM
response. Additional immunization of mice receiving the protein extract
further increased IgG levels, with a drop in IgM levels (data not
shown). Further immunization of the whole-oocyst control group still
produced a predominant IgM response, with no increase in IgG levels,
and the oocyst wall group produced no IgG or IgM response. Of the three
extracts (8), only one (BME) gave a weak IgM response to the
oocyst wall. The highest-response soluble-protein extract mouse was
chosen for the fusion procedure. This analysis resulted in the
production of nine MAbs against the oocyst wall: eight IgMs and one the
IgG1 MAb Cry104.
|
Analysis of antibodies for oocyst staining in water samples.
Figure 2 compared three MAbs (2 µg/ml)
for the differentiation of C. parvum oocysts and particles
in concentrates from environmental water samples. Cry104, the IgG1
antibody produced for this report, gave the greatest separation of
oocysts from particles present in water concentrates and the highest
mean fluorescence intensity (MFI) of the oocyst population (i.e.,
4,500). Oocysts stained with Cry104 also had formed a tight group with
little scatter, indicating constant levels of this antigen on each
oocyst and reproducible fluorescence staining. The MAb Cry26 is an IgM
routinely used for examination of water samples (15), and
15H10 is another IgM MAb generated in our laboratory. Both of the IgM
MAbs, Cry26 and 15H10, showed a more dispersed fluorescence population
of oocysts than did Cry104 and less separation of the oocyst population from debris in water. This reduced separation corresponds to lower MFI
values for the oocyst populations of 1,200 (Cry26) and 1,900 (15H10)
compared with an MFI of 4,500 for Cry104.
|
Western blot examination of serum samples and MAbs.
Western
blots of sera from mice immunized with whole oocysts (control group),
oocyst walls, and soluble extract (Fig.
3) demonstrated an immune response to a
large number of bands. The whole-oocyst control group and the
soluble-protein-extract sera reacted with multiple bands of from >100
kDa down to 30 kDa as described by Tilley et al. (20).
|
Functional measurement of avidity.
The binding curves of the
three MAbs Cry26, Cry104, and Immucell in response to 107
oocysts is shown in Fig. 4. Data obtained
from these plots were then used to calculate the relative avidity of
the whole MAbs (Table 1). MAb Cry104
possessed the highest avidity, with a 50% binding at less than half
the concentration of Cry26. This indicates that Cry104 has the highest
avidity to C. parvum oocysts. Twice as much Cry26 was
required for 50% binding, and more than 10 times as much of the
Immucell antibody was required.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
During immunization, mice were monitored for both IgM and IgG antibodies against oocyst surface antigens. The whole-oocyst control mice produced a high IgM response, with little or no IgG. This would suggest that there was little T-cell-dependent immune response (i.e., shift to IgG) and that immunization directly stimulated B cells, resulting directly in less isotype switching and reduced affinity maturation in the MAbs produced (7). Hence, IgM antibodies dominate the immune response. This may be due to C. parvum oocysts having a complex polysaccharide at their surface. The presence of sporozoites in this preparation may have also reduced the immungenicity. McDonald et al. (12) showed that the sporozoite is highly immunogenic compared to the oocyst wall, with <10% of the hybridomas against whole oocysts reacting with the oocyst wall. Therefore, sporozoites were removed when preparing both the purified oocyst wall and the soluble extract to maximize the response to the oocyst wall.
The mice receiving purified oocyst walls showed no immune response to surface epitopes and in Western blots reacted only weakly with a restricted number of antigens. Despite the use of Freund adjuvant, the purified oocyst walls were substantially less immunogenic than the inactivated whole oocysts. The purified walls were intact apart from the longitudinal slit that releases the internal contents, so presumably the difference is due to the absence of immunogenic internal antigens. This also suggests that without sporozoites present there is limited immunogenicity, as suggested by Tzipori (21). There is no evidence that excystation could alter or denature the outer epitopes of the oocyst walls, thus making them different from those of naturally occurring oocysts. This is evident since excysted oocysts can still be stained with MAbs against the oocyst wall (25).
The mice receiving soluble oocyst extract demonstrated a moderate IgM and a strong secondary IgG response. After the large oocyst wall structure is broken up into smaller complexes by SDS extraction and then precipitated out the oocyst wall, proteins become T-cell-dependent antigens. After further immunizations with soluble extract (data not shown), the IgG response further increased, while the IgM response decreased. This was not observed in the whole-oocyst control or purified wall group, which showed a predominant IgM response or no response, respectively, after each immunization. A possible explanation for these results is the large (5-µm) size of the oocysts wall being too large for T-cell processing, thus allowing stimulation of low-affinity B cells (i.e., B cells producing IgM).
Antigens used by other workers (8) were also evaluated for the production of antibodies to the oocyst surface. The mice immunized with OCA and TRE preparations showed no response to the oocyst wall. The antisera reacted with internal membrane on excysted oocysts and not the oocyst surface. The BME antigen produced a very weak IgM response against the oocyst wall even though it was solubilized in SDS (2 min) similarly to the soluble oocyst extract. The difference may be due to the sequential preparation of these antigens. Removing the internal proteins could have affected the structure of the BME antigen either by a change in structure or integrity. The lack of immune response to the BME and purified-oocyst-wall antigens demonstrates that the oocyst wall carbohydrate structure is not very immunogenic.
In the Western blot analysis, bands covering a size range of >100 kDa to approximately 36 kDa all carried the same epitopes, as defined by MAb binding. The results are consistent with the epitopes being an oligosaccharide carried on several different proteins. Previous work (13) has demonstrated that epitopes on the oocyst wall are sensitive to sodium meta-periodate treatment, indicating that they have carbohydrate components.
In this study evaluation by fluorescence microscopy showed uniform staining of the oocyst wall, suggesting that a common antigen covers the oocyst wall. Competition studies between the MAbs Cry26 and Cry104 (results not shown) utilizing different fluorescent labels on each MAb demonstrated that these MAbs do recognize a common epitope and compete for binding sites. However, MAbs analyzed by Western blot analysis showed differences in banding patterns, suggesting that they recognize slightly different structures.
The functional avidity of Cry104 was compared with other
anti-Cryptosporidium antibodies. The 50% binding level for
the IgG1 (Cry104) whole antibody was calculated to be 7 × 108 mol
1, i.e., less than half that of the
other antibodies tested (Table 1).
The high avidity of Cry104 is also reflected in the water sample analysis (Fig. 2). Cry104 gave the tightest cluster of oocysts and the best separation from debris in concentrated environmental water samples. Similar findings were reported previously (6). This high signal-to-noise ratio is desirable for water testing by flow cytometry. Increased differentiation of oocysts from debris means fewer nonspecific fluorescent debris particles are detected and analyzed by the cytometer, allowing increased analysis speeds and so reducing analysis time. This will allow analytical laboratories to more accurately and reliably test concentrated water samples for Cryptosporidium spp.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by a collaborative Commonwealth Department of Industry, Science and Tourism grant (DIST), with additional financial support from Australian Water Technologies and Becton Dickinson.
We thank Australian Water Technologies for the supply of concentrated water samples. The IgG1 MAb Cry104 is the subject of International Patent Application number PCT/AV98/00368.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: BioTechnology Frontiers, P.O. Box 599, North Ryde BC, NSW 1670, Australia. Phone: 612-98992167. Fax: 612-98891805. E-mail: chrisweir{at}biotecfrontiers.com.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bukhari, Z.,
R. M. McCuin,
C. R. Fricker, and J. L. Clancy.
1998.
Immunomagnetic separation of Cryptosporidium parvum from source water samples of various turbidities.
Appl. Environ. Microbiol.
64:4495-4499 |
| 2. | Catty, D. 1988. Antibodies: a practical approach, p. 7-58. IRL Press, Oxford, England. |
| 3. |
Connolly, G. M.,
M. S. Dryden,
D. C. Shanson, and B. G. Gazzard.
1988.
Cryptosporidial diarrhoea in AIDS and its treatment.
Gut
29:593-597 |
| 4. |
Dupont, H. L.,
C. L. Chappell,
C. R. Sterling,
J. B. Rose, and W. Jakubowski.
1995.
The infectivity of Cryptosporidium parvum in healthy volunteers.
N. Engl. J. Med.
332:855-859 |
| 5. | Ey, P. L., S. J. Prowse, and C. R. Jenkin. 1978. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Biochemistry 15:129-144. |
| 6. | Ferrari, B. C., G. Vesey, C. J. Weir, K. L. Williams, and D. A. Veal. 1999. Comparison of Cryptosporidium-specific and Giardia-specific monoclonal antibodies for monitoring water samples. Water Res. 33:1611-1617[CrossRef]. |
| 7. | Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual, p. 53-136. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 8. | Hornok, S., Z. Szell, J. Nieuwenhuijs, M. G. B. Nieuwland, A. W. C. A. Cornelissen, and I. Varga. 1998. Immunogenicity of three oocyst extracts of Cryptosporidium baileyi in experimentally infected chickens. Parasitol. Res. 85:71-77[CrossRef]. |
| 9. | Karanis, P., D. Schoenen, W. A. Maier, and H. M. Seitz. 1993. Drinking water and parasites. Immun. Infekt. 21:132-136[Medline]. |
| 10. | Khyse-Andersen, J. 1984. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Methods 10:203-209[CrossRef][Medline]. |
| 11. |
Luft, B. J.,
D. Payne,
D. Woodmansee, and C. W. Kim.
1987.
Characterization of the Cryptosporidium antigens from sporulated oocysts of Cryptosporidium parvum.
Infect. Immun.
55:2436-2441 |
| 12. | McDonald, V., R. M. A. Deer, J. M. S. Nina, S. Wright, P. L. Chiodini, and K. P. W. J. McAdam. 1991. Characteristics and specificity of hybridoma antibodies against oocyst antigens of Cryptosporidium parvum from man. Parasite Immunol. 13:251-259[Medline]. |
| 13. | Moore, A. G., G. Vesey, A. Champion, P. Scandizzo, D. Deere, D. Veal, and K. L. Williams. 1998. Viable Cryptosporidium parvum oocysts exposed to chlorine or other oxidising conditions may lack identifying epitopes. Int. J. Parasitol. 28:1205-1212[CrossRef][Medline]. |
| 14. | O'Donoghue, P. J. 1995. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25:1-55. |
| 15. | Pererva, N. 1998. Cryptosporidium parvum antigens and ultrastructure. Ph.D. thesis. Macquarie University, Sydney, Australia. |
| 16. | Robertson, L. J., A. T. Campbell, and H. V. Smith. 1993. In vitro excystation of Cryptosporidium parvum. Parasitology 106:13-19. |
| 17. | Robertson, L. J., A. T. Campbell, and H. V. Smith. 1992. Survival of Cryptosporidium parvum oocysts under various environmental pressures. Appl. Environ. Microbiol. 58:494-500. |
| 18. | Roitt, I., J. Brostoff, and D. Male. 1996. Immunology, 4th ed., p. 107-129. Mosby Publications, London, England. |
| 19. | Smith, H. V., and J. B. Rose. 1990. Waterborne cryptosporidiosis. Parasitol. Today 6:8-12[CrossRef][Medline]. |
| 20. |
Tilley, N.,
R. Fayer,
A. Guidry,
S. J. Upton, and B. L. Blagburn.
1990.
Cryptosporidium parvum (Apicomplexa: Cryptosporidiae) oocysts and sporozoite antigens recognized by bovine colostral antibodies.
Infect. Immun.
58:2966-2971 |
| 21. | Tzipori, S. 1988. Cryptosporidiosis in perspective. Adv. Parasitol. 27:63-129[Medline]. |
| 22. | Vesey, G., J. S. Slade, M. Byrne, K. Shepherd, P. J. Dennis, and C. R. Fricker. 1993. Routine monitoring of Cryptosporidium oocysts in water using flow cytometry. J. Appl. Bacteriol. 75:87-90[Medline]. |
| 23. | Vesey, G. 1996. Application of flow cytometry to the detection of Cryptosporidium in water. Ph.D. thesis. Macquarie University, Sydney, Australia. |
| 24. | Vesey, G., D. Deere, C. J. Weir, N. Ashbolt, K. L. Williams, and D. A. Veal. 1997. A simple method for evaluating Cryptosporidium-specific antibodies for monitoring environmental water samples. Lett. Appl. Microbiol. 25:316-320[CrossRef][Medline]. |
| 25. | Vesey, G., K. R. Griffiths, M. R. Gauci, D. Deere, K. L. Williams, and D. A. Veal. 1997. A simple and rapid measurement of Cryptosporidium excystation using flow cytometry. Int. J. Parasitol. 27:1353-1359[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»